Immunization and Vaccination are crucial components of public health strategies aimed at preventing infectious diseases and protecting individuals and communities from their harmful effects. While the terms "immunization" and "vaccination" are often used interchangeably, they refer to distinct but related concepts within the realm of disease prevention.
Vaccination refers specifically to the process of administering a vaccine, a biological preparation that stimulates the immune system to recognize and mount a protective response against a particular pathogen, such as a virus or bacterium. Vaccines can contain live, weakened, or inactivated forms of the pathogen, as well as specific components or antigens derived from the pathogen. Immunization, on the other hand, refers to the overall process of inducing immunity to a disease through vaccination or by other means, such as natural infection. Immunization can lead to the development of long-lasting immunity, providing protection against future encounters with the pathogen.
The goal of immunization and vaccination programs is to achieve herd immunity, also known as community immunity, where a significant proportion of the population is immune to a disease, thereby reducing the overall transmission and prevalence of the disease within the community. This not only protects vaccinated individuals but also provides indirect protection to those who are not vaccinated, such as infants, elderly individuals, and those with compromised immune systems. Immunization and vaccination have been instrumental in controlling and eradicating many infectious diseases that were once widespread and deadly. Diseases such as smallpox, polio, and measles have been effectively controlled or eliminated in many parts of the world through vaccination campaigns and routine immunization programs.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States